Select for export Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults Details DOI 10.1016/j.amepre.2026.108381 PubMed 42092643 Copy citation Copy BibTeX American Journal of Preventive Medicine 2026-05-03 Kevin H. Yang, Nora Satybaldiyeva, Wayne Kepner, Joseph Friedman, Siyuan Ping, Eric C. Leas OpenAlex Published psilocybin MicrodosingClinical TrialToxicity Clinical Trial MDMA More